光热治疗
肿瘤微环境
致病菌
细菌
免疫疗法
免疫原性
癌症研究
免疫系统
免疫学
生物
材料科学
纳米技术
遗传学
作者
Xiaolong Xu,Youbin Ding,Yafang Dong,Haitao Yuan,Peng Xia,Chengming Qu,Jingbo Ma,Huifang Wang,Xiaodong Zhang,Liang Zhao,Zhijie Li,Zhen Liang,Jigang Wang
出处
期刊:Advanced Science
[Wiley]
日期:2024-06-18
卷期号:11 (31): e2401905-e2401905
被引量:22
标识
DOI:10.1002/advs.202401905
摘要
Bacteria can be utilized for cancer therapy owing to their preferential colonization at tumor sites. However, unmodified non-pathogenic bacteria carry potential risks due to their non-specific targeting effects, and their anti-tumor activity is limited when used as monotherapy. In this study, a biohybrid-engineered bacterial system comprising non-pathogenic MG1655 bacteria modified with CDH17 nanobodies on their surface and conjugated with photosensitizer croconium (CR) molecules is developed. The resultant biohybrid bacteria can efficiently home to CDH17-positive tumors, including gastric, pancreatic, and colorectal cancers, and significantly suppress tumor growth upon irradiation. More importantly, biohybrid bacteria-mediated photothermal therapy (PTT) induced abundant macrophage infiltration in a syngeneic murine colorectal model. Further, that the STING pathway is activated in tumor macrophages by the released bacterial nucleic acid after PTT is revealed, leading to the production of type I interferons. The addition of CD47 nanobody but not PD-1 antibody to the PTT regimen can eradicate the tumors and extend survival. This results indicate that bacteria endowed with tumor-specific selectivity and coupled with photothermal payloads can serve as an innovative strategy for low-immunogenicity cancers. This strategy can potentially reprogram the tumor microenvironment by inducing macrophage infiltration and enhancing the efficacy of immunotherapy targeting macrophages.
科研通智能强力驱动
Strongly Powered by AbleSci AI